MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0021631
Real Drugs Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹2.04 Cr
▼ 76% YoY
Net loss · FY 2026
₹26.73 Lakh
Net margin -13.1%
EBITDA · FY 2026
₹1.07 Cr
EBITDA margin 52.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹2.5 Cr
Secured borrowings
Company age
22 yrs
Est. 2004
Directors on board
3
As per MCA filings
About Real Drugs Private Limited
Data last updated:
Real Drugs Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 October 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2004PTC129775. Its GSTIN is 07AACCR9568D1Z4 (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kapil Goyal and Manoj Kumar Jha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Unit No. 1201 12th Floor, D – Mall Netaji Subhash Place Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2026, the company reported a revenue of ₹2.04 Cr, a decline of 76% compared to the previous year. For the same year it recorded a net loss of ₹26.73 Lakh (net margin -13.1%) and EBITDA of ₹1.07 Cr (EBITDA margin 52.3%). Revenue has grown at a compounded annual rate (CAGR) of 95% over three years and 7% over five years.
The company is associated with 1 brand: Real Drugs. As per MCA filings, the company has open charges of ₹2.5 Cr on record.
Real Drugs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0021631). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website realdrugs.in.
Company details
CIN U24239DL2004PTC129775
Registration Number 129775
Incorporation Date 08 October 2004
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0021631
Recognitions & Rankings of Real Drugs
Contact details
Real Drugs Private Limited's registered office is in Delhi, Delhi. Its website is realdrugs.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No. 1201 12th Floor, D – Mall Netaji Subhash Place Pitampura, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Real Drugs Private Limited, buy the company report.
Comprehensive company report
Real Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Real Drugs operates one associated brand: Real Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality generic dosage forms and active pharmaceutical ingredients (APIs). | realdrugs.in |
Business activity
The main business activity of Real Drugs is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Real Drugs Private Limited, buy the company report.
Financials of Real Drugs Private Limited
FY 2026 filings availableReal Drugs Private Limited reported revenue of ₹2.04 Cr (down 76% YoY) for FY 2026.
Revenue · FY 2026
₹2.04 Cr ▼ 76%
Net loss · FY 2026
₹26.73 Lakh margin -13.1%
EBITDA · FY 2026
₹1.07 Cr margin 52.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 76%
3 years · compounded
▲ 95%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 522%
Revenue fell 76% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA rose 522% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2.04 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.07 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹26.73 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 52.3% | ||||
| Net Profit Margin | -13.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Real Drugs Private Limited, buy the company report.
Board of directors of Real Drugs Private Limited
Real Drugs has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kapil Goyal Also directs: KK Biologics LLP | Director | 23 Jun 2021 | 5 Years 4 Months | Current |
| Manoj Kumar Jha Also directs: Cureclip Pharmaceuticals Limited | Director | 19 Sep 2024 | 2 Years 1 Months | Current |
| Naresh Kumar Goyal Also directs: DJ Biotech LLP, DJ Biotech Private Limited, Cureclip Pharmaceuticals Limited and 2 more | Director | 23 Sep 2024 | 2 Years 1 Months | Current |
Auditor
Real Drugs Private Limited is audited by MEHRA CHOUDHARY & CO. for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MEHRA CHOUDHARY & CO. | FY 2026 | 009429N |
Shareholding
The shareholding of Real Drugs Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Real Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jun 2024 | 100954970 | Hdfc Bank Limited | ₹2.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Real Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Real Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Real Drugs has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCR9568D1Z4 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Real Drugs Private Limited, buy the company report.
Recent activity
Real Drugs Private Limited has 13 board changes on record since 2004: 8 appointments and 5 cessations. The latest: Naresh Kumar Goyal was appointed as Director on 23 Sep 2024.
Filing
Real Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi Ii.
AGM
Real Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Naresh Kumar Goyal was appointed as Director.
Appointed
Manoj Kumar Jha was appointed as Director.
Ceased
Pawan Kumar ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 250.00 Lakh with Charge ID 100954970 was registered on 19 Jun 2024.
Appointed
Pawan Kumar was appointed as Director.
Ceased
Vivek Goyal ceased to be Director.
Appointed
Kapil Goyal was appointed as Director.
Ceased
Manish Goel ceased to be Director.
Appointed
Manish Goel was appointed as Director.
Ceased
Rakesh Prasad ceased to be Director.
5 earlier events are in the company report.
Frequently asked questions
Real Drugs is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 October 2004 (22+ years old) and is registered under CIN U24239DL2004PTC129775.
Real Drugs has 3 current directors:
- Kapil Goyal - Director
- Manoj Kumar Jha - Director
- Naresh Kumar Goyal - Director
The latest financial statements of Real Drugs on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Real Drugs is 07AACCR9568D1Z4, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Real Drugs is U24239DL2004PTC129775. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Real Drugs was incorporated on 08 October 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Naresh Kumar Goyal was appointed as Director on 23 Sep 2024. Manoj Kumar Jha was appointed as Director on 19 Sep 2024. Pawan Kumar ceased to be Director on 01 Jul 2024. Real Drugs has 13 board changes on record in total.
Yes, Real Drugs is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0021631).
Real Drugs can be reached through the website realdrugs.in. Its registered office is in Delhi, India.
The registered office of Real Drugs is at Unit No. 1201 12th Floor, D – Mall Netaji Subhash Place Pitampura, Delhi, India – 110034.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages